Your browser doesn't support javascript.
Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE).
Abootalebi, Shahram; Aertker, Benjamin M; Andalibi, Mohammad Sobhan; Asdaghi, Negar; Aykac, Ozlem; Azarpazhooh, M Reza; Bahit, M Cecilia; Barlinn, Kristian; Basri, Hamidon; Shahripour, Reza Bavarsad; Bersano, Anna; Biller, Jose; Borhani-Haghighi, Afshin; Brown, Robert D; Campbell, Bruce Cv; Cruz-Flores, Salvador; De Silva, Deidre Anne; Di Napoli, Mario; Divani, Afshin A; Edgell, Randall C; Fifi, Johanna T; Ghoreishi, Abdoreza; Hirano, Teruyuki; Hong, Keun-Sik; Hsu, Chung Y; Huang, Josephine F; Inoue, Manabu; Jagolino, Amanda L; Kapral, Moira; Kee, Hoo Fan; Keser, Zafer; Khatri, Rakesh; Koga, Masatoshi; Krupinski, Jerzy; Liebeskind, David S; Liu, Liping; Ma, Henry; Maud, Alberto; McCullough, Louise D; Meyer, Dawn Matherne; Mifsud, Victoria; Morovatdar, Negar; Nilanont, Yongchai; Oxley, Thomas J; Özdemir, Atilla Özcan; Pandian, Jeyaraj; Pantoni, Leonardo; Papamitsakis, Nikolaos I H; Parry-Jones, Adrian; Phan, Thanh.
  • Abootalebi S; Dr. Everett Chalmers Regional Hospital, Dalhousie University, New Brunswick, Canada. Electronic address: dr.shahram.abootalebi@horizonnb.ca.
  • Aertker BM; Department of Neurology, UTHealth McGovern Medical School, The University of Texas at Houston, Houston, Texas, USA. Electronic address: benjamin.m.aertker@uth.tmc.edu.
  • Andalibi MS; International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: mssha96@gmail.com.
  • Asdaghi N; Department of Neurology, University of Miami, Miami, Florida, USA. Electronic address: nasdaghi@med.miami.edu.
  • Aykac O; Department of Neurology and Neurocritical Care, Eskisehir Osmangazi University, Eskisehir, Turkey.
  • Azarpazhooh MR; Stroke Prevention and Atherosclerosis Research Centre, Robarts Research Institute, Western University, London, Ontario, Canada; Department of Clinical Neurological Sciences, Western University, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Den
  • Bahit MC; Chief of Cardiology, INECO Neurociencias, Rosario, Argentina.
  • Barlinn K; Department of Neurology, Carl Gustav Carus University Hospital, Technische Universität Dresden, Dresden, Germany. Electronic address: Kristian.Barlinn@ukdd.de.
  • Basri H; Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia. Electronic address: hamidon@upm.edu.my.
  • Shahripour RB; University of Tennessee, Comprehensive Stroke center, Memphis, Tennessee, USA. Electronic address: rbavarsa@uthsc.edu.
  • Bersano A; Fondazione Istituto Neurologico 'Carlo Besta', Milan, Italy. Electronic address: anna.bersano@istituto-besta.it.
  • Biller J; Department of Neurology, Loyola University Health System, Stritch School of Medicine, Chicago, USA. Electronic address: JBILLER@lumc.edu.
  • Borhani-Haghighi A; Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Brown RD; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: brown@mayo.edu.
  • Campbell BC; Department of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, University of Melbourne, Parkville, Australia. Electronic address: bruce.campbell@mh.org.au.
  • Cruz-Flores S; Neurology Department, Texas Tech Health University, El Paso, Texas, USA. Electronic address: salvador.cruz-flores@ttuhsc.edu.
  • De Silva DA; National Neuroscience Institute, Singapore General Hospital campus, Singapore. Electronic address: deidre.desilva@singhealth.com.sg.
  • Di Napoli M; Department of Neurology and Stroke Unit, San Camillo de' Lellis General District Hospital, Rieti, Italy; Neurological Section, Neuro-epidemiology Unit, SMDN-Centre for Cardiovascular Medicine and Cerebrovascular Disease Prevention, Sulmona, L'Aquila, Italy. Electronic address: mariodinapoli@katamail
  • Divani AA; Department of Neurology, School of Medicine, University of New Mexico, Albuquerque, New Mexico, USA.
  • Edgell RC; Department of Neurology, Souers Stroke Institute, Saint Louis University, USA.
  • Fifi JT; Departments of Neurology and Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, USA. Electronic address: Johanna.fifi@mountsinai.org.
  • Ghoreishi A; Department of Neurology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Hirano T; Department of Stroke and Cerebrovascular Medicine, Kyorin University, Japan. Electronic address: terry@ks.kyorin-u.ac.jp.
  • Hong KS; Department of Neurology, Inje University, Ilsan Paik Hospital, Goyang, Republic of Korea.
  • Hsu CY; Graduate Institute of Clinical Medical Science, China Medical University, Taipei, Taichung. Electronic address: hsuc@mail.cmu.edu.tw.
  • Huang JF; Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA. Electronic address: huang.josephine@mayo.edu.
  • Inoue M; Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan. Electronic address: gakinoue@ncvc.go.jp.
  • Jagolino AL; Department of Neurology, UTHealth McGovern Medical School, The University of Texas at Houston, Houston, Texas, USA. Electronic address: amanda.l.jagolino@uth.tmc.edu.
  • Kapral M; Department of Medicine and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada; Institute for Clinical Evaluative Sciences, Toronto, Canada. Electronic address: Moira.Kapral@uhn.ca.
  • Kee HF; Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.
  • Keser Z; Department of Neurology, UTHealth McGovern Medical School, The University of Texas at Houston, Houston, Texas, USA. Electronic address: Zafer.Keser@uth.tmc.edu.
  • Khatri R; Neurology Department, Texas Tech Health University, El Paso, Texas, USA. Electronic address: rakesh.khatri@ttuhsc.edu.
  • Koga M; Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan. Electronic address: koga@ncvc.go.jp.
  • Krupinski J; Department of Neurology, Hospital Universitari MutuaTerrassa, Terrassa (Barcelona), Spain; Department of Life Sciences, CBS, Manchester Metropolitan University, Manchester, UK. Electronic address: jkrupinski@mutuaterrassa.es.
  • Liebeskind DS; Department of Neurology, Geffen School of Medicine, UCLA, USA. Electronic address: dliebeskind@mednet.ucla.edu.
  • Liu L; Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing, China.
  • Ma H; Department of Neurology, Monash Health and Department of Medicine, School of Clinical Sciences Monash University, Australia.
  • Maud A; Neurology Department, Texas Tech Health University, El Paso, Texas, USA.
  • McCullough LD; Department of Neurology, UTHealth McGovern Medical School, The University of Texas at Houston, Houston, Texas, USA. Electronic address: Louise.D.McCullough@uth.tmc.edu.
  • Meyer DM; Department of Neurosciences, UCSD, USA. Electronic address: dmmeyer@health.ucsd.edu.
  • Mifsud V; Neurologic Institute, Cleveland Clinic Abu Dhabi, UAE. Electronic address: MifsudV@clevelandclinicabudhabi.ae.
  • Morovatdar N; Clinical Research Development Unit, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: MorovatdarN@mums.ac.ir.
  • Nilanont Y; Siriraj Stroke Center, Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Oxley TJ; Department of Neurosurgery, Mount Sinai Hospital, New York, USA. Electronic address: tomoxl@mac.com.
  • Özdemir AÖ; Department of Neurology and Neurocritical Care, Eskisehir Osmangazi University, Eskisehir, Turkey.
  • Pandian J; Department of Neurology, Christian Medical College, Ludhiana, India.
  • Pantoni L; Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy. Electronic address: leonardo.pantoni@unimi.it.
  • Papamitsakis NIH; Department of Neurology, SUNY Downstate Medical Center, Brooklyn, New York, USA.
  • Parry-Jones A; Manchester Centre for Clinical Neurosciences, Salford Royal National Health Service Foundation Trust, Manchester Academic Health Science Centre, Salford, UK. Electronic address: adrian.parry-jones@manchester.ac.uk.
  • Phan T; Department of Neurology, Monash Health and Department of Medicine, School of Clinical Sciences Monash University, Australia. Electronic address: thanh.phan@monash.edu.
J Stroke Cerebrovasc Dis ; 29(9): 104938, 2020 Sep.
Article in English | MEDLINE | ID: covidwho-210006
ABSTRACT
BACKGROUND AND

PURPOSE:

The novel severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), now named coronavirus disease 2019 (COVID-19), may change the risk of stroke through an enhanced systemic inflammatory response, hypercoagulable state, and endothelial damage in the cerebrovascular system. Moreover, due to the current pandemic, some countries have prioritized health resources towards COVID-19 management, making it more challenging to appropriately care for other potentially disabling and fatal diseases such as stroke. The aim of this study is to identify and describe changes in stroke epidemiological trends before, during, and after the COVID-19 pandemic.

METHODS:

This is an international, multicenter, hospital-based study on stroke incidence and outcomes during the COVID-19 pandemic. We will describe patterns in stroke management, stroke hospitalization rate, and stroke severity, subtype (ischemic/hemorrhagic), and outcomes (including in-hospital mortality) in 2020 during COVID-19 pandemic, comparing them with the corresponding data from 2018 and 2019, and subsequently 2021. We will also use an interrupted time series (ITS) analysis to assess the change in stroke hospitalization rates before, during, and after COVID-19, in each participating center.

CONCLUSION:

The proposed study will potentially enable us to better understand the changes in stroke care protocols, differential hospitalization rate, and severity of stroke, as it pertains to the COVID-19 pandemic. Ultimately, this will help guide clinical-based policies surrounding COVID-19 and other similar global pandemics to ensure that management of cerebrovascular comorbidity is appropriately prioritized during the global crisis. It will also guide public health guidelines for at-risk populations to reduce risks of complications from such comorbidities.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Practice Patterns, Physicians' / Coronavirus Infections / Stroke / Betacoronavirus / Hospitalization Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: J Stroke Cerebrovasc Dis Journal subject: Vascular Diseases / Brain Year: 2020 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Practice Patterns, Physicians' / Coronavirus Infections / Stroke / Betacoronavirus / Hospitalization Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: J Stroke Cerebrovasc Dis Journal subject: Vascular Diseases / Brain Year: 2020 Document Type: Article